US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals(Delisted)

Watchlist
  • 59.980
  • 0.0000.00%
Close Nov 29 13:00 ET
2.34BMarket Cap-26.66P/E (TTM)

Longboard Pharmaceuticals(Delisted) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
107.07%28.12M
63.94%25.64M
51.40%18.11M
26.70%56.76M
32.80%15.57M
14.29%13.58M
35.23%15.64M
24.35%11.96M
60.92%44.8M
33.35%11.73M
Selling and administrative expenses
115.71%6.67M
67.35%5.2M
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
-General and administrative expense
115.71%6.67M
67.35%5.2M
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
Research and development costs
104.52%21.45M
63.09%20.45M
54.40%13.17M
26.31%43.75M
32.69%12.2M
11.54%10.49M
40.52%12.54M
19.79%8.53M
75.17%34.64M
44.36%9.19M
Operating profit
-107.07%-28.12M
-63.94%-25.64M
-51.40%-18.11M
-26.70%-56.76M
-32.80%-15.57M
-14.29%-13.58M
-35.23%-15.64M
-24.35%-11.96M
-60.92%-44.8M
-33.35%-11.73M
Net non-operating interest income expense
452.11%3.66M
491.67%3.91M
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
Non-operating interest income
452.11%3.66M
491.67%3.91M
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
Other net income (expense)
-407.14%-71K
-176.47%-47K
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
Other non- operating income (expenses)
-407.14%-71K
-176.47%-47K
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
Income before tax
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Income tax
Net income
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Net income continuous Operations
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Minority interest income
Net income attributable to the parent company
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Basic earnings per share
-14.55%-0.63
13.85%-0.56
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.00%-0.56
-32.64%-2.56
-26.92%-0.66
Diluted earnings per share
-14.55%-0.63
13.85%-0.56
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.30%-0.56
-32.64%-2.56
-26.92%-0.66
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 107.07%28.12M63.94%25.64M51.40%18.11M26.70%56.76M32.80%15.57M14.29%13.58M35.23%15.64M24.35%11.96M60.92%44.8M33.35%11.73M
Selling and administrative expenses 115.71%6.67M67.35%5.2M43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M
-General and administrative expense 115.71%6.67M67.35%5.2M43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M
Research and development costs 104.52%21.45M63.09%20.45M54.40%13.17M26.31%43.75M32.69%12.2M11.54%10.49M40.52%12.54M19.79%8.53M75.17%34.64M44.36%9.19M
Operating profit -107.07%-28.12M-63.94%-25.64M-51.40%-18.11M-26.70%-56.76M-32.80%-15.57M-14.29%-13.58M-35.23%-15.64M-24.35%-11.96M-60.92%-44.8M-33.35%-11.73M
Net non-operating interest income expense 452.11%3.66M491.67%3.91M507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K
Non-operating interest income 452.11%3.66M491.67%3.91M507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K
Other net income (expense) -407.14%-71K-176.47%-47K10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K
Other non- operating income (expenses) -407.14%-71K-176.47%-47K10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K
Income before tax -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Income tax
Net income -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Net income continuous Operations -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Minority interest income
Net income attributable to the parent company -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Basic earnings per share -14.55%-0.6313.85%-0.5625.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.00%-0.56-32.64%-2.56-26.92%-0.66
Diluted earnings per share -14.55%-0.6313.85%-0.5625.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.30%-0.56-32.64%-2.56-26.92%-0.66
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data